利用质谱技术对超大型复合物中PF4与长链肝素寡糖结合的新见解
本研究采用液相色谱-质谱联用及多反应监测技术,分析PF4与依诺肝素在不同摩尔比和浓度下孵育后形成的复合物特征,发现PF4与依诺肝素形成超大型复合物比例最高的摩尔比为2:1,且超大型复合物中PF4四聚体与依诺肝素摩尔比约为2:1,据此提出一个肝素寡糖链(约dp18)结合2个PF4四聚体形成超大型复合物的结合模型。
要点
- PF4与依诺肝素形成超大型复合物比例最高的摩尔比为PF4/依诺肝素2:1。
- 超大型复合物中PF4四聚体与依诺肝素摩尔比约为2:1。
- 提出一个肝素寡糖链(约dp18)结合2个PF4四聚体形成超大型复合物的模型。
核心结论
- 提出PF4与依诺肝素在超大型复合物中的结合模型:一个肝素寡糖链(约dp18)以不同形态结合2个PF4四聚体形成超大型复合物,而PF4四聚体在较小复合物中被多条肝素链包围。
- 研究为PF4-低分子量肝素相互作用的结构机制提供新见解,有助于进一步理解低分子量肝素免疫原性机制并开发更安全的肝素产品。
研究设计与样本
- 采用多种分析方法,特别是液相色谱-质谱联用和液相色谱-串联质谱多反应监测技术,对PF4-依诺肝素复合物进行定性和定量监测。
- 分析PF4-依诺肝素复合物在不同摩尔比和浓度下孵育后的特征。
主要发现
- PF4与依诺肝素形成超大型复合物比例最高的摩尔比为PF4/依诺肝素2:1。
- 超大型复合物中PF4四聚体与依诺肝素的摩尔比约为2:1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heparin-induced thrombocytopenia (HIT) is a serious complication caused by heparin drugs. The ultralarge complexes formed by platelet factor 4 (PF4) with heparin or low molecular weight heparins (LMWHs) are important participants in inducing the immune response and HIT. OBJECTIVES: We aim at characterizing the interaction between PF4 and long-chain heparin oligosaccharides and providing robust analytical methods for the analysis of PF4-heparin complexes. METHODS: In this work, the characteristics of PF4-enoxaparin complexes after incubation in different molar ratios and concentrations were analyzed by multiple analytical methods, especially liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry with multiple reaction monitoring were developed to qualitatively and quantitatively monitor heparin oligosaccharides and PF4 in HIT-inducing complexes. RESULTS: The results showed that the largest proportion of ultralarge complexes formed by PF4 and enoxaparin was at a specific molar ratio, ie, a PF4/enoxaparin ratio of 2:1, while the ultralarge complexes contained PF4 tetramer and enoxaparin at a molar ratio of approximately 2:1. CONCLUSION: A binding model of PF4 and enoxaparin in ultralarge complexes is proposed with one heparin oligosaccharide chain (∼ dp18) bound to 2 PF4 tetramers in different morphologies to form ultralarge complexes, while PF4 tetramer is surrounded by multiple heparin chains in smaller complexes. Our study provides new insights into the structural mechanism of PF4-LMWH interaction, which help to further understand the mechanism of LMWH immunogenicity and develop safer heparin products.
引用
- Shi D, Zhao H, Bu C, et al. New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry. J Thromb Haemost. 2023. PMID: 37648114. doi:10.1016/j.jtha.2023.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。